PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

Ann: 2022 Annual Report and Appendix 4E, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,037 Posts.
    lightbulb Created with Sketch. 326
    Definitely a short term focus on MPS. Would say this is where Marco is spending most of his time for now. Clearly where PAR expects shorter turnaround into revenues.

    OA the slow burn.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.